University to Study Genetics Role in Vaccine Response

Article

The University of Alabama at Birmingham (UAB) has received a five-year, $12 million contract from the National Institute of Allergy and Infectious Diseases to study genetic factors that influence how well individuals respond to the anthrax vaccine.

 

This research will provide valuable information about individual differences in immune response and in adverse reactions to the anthrax vaccine, says Richard Kaslow, MD, professor of epidemiology in the School of Public Health at UAB.

 

The investigation will rely heavily on information gathered from an ongoing study of the anthrax vaccine under way at several medical research institutions, including UAB.

 

Hopefully, our work will give us greater insight into the way the vaccine works and the role of genetics in determining response, Kaslow adds.

 

Source: University of Alabama at Birmingham    

Recent Videos
Infection Control Today's Infection Intel: Staying Ahead With Company Updates and Product Innovations.
COVID-19 presentations at IDWeek in Las Angeles, California by Invivyd.   (Adobe Stock 333039083 by Production Perig)
Long COVID and Other Post-Viral Syndromes
Meet Jenny Hayes, MSN, RN, CIC, CAIP, CASSPT.
Infection Control Today Editorial Advisory Board: Fibi Attia, MD, MPH, CIC.
Andrea Thomas, PhD, DVM, MSc, BSc, director of epidemiology at BlueDot
mpox   (Adobe Stock 924156809 by Andreas Prott)
Meet Alexander Sundermann, DrPH, CIC, FAPIC.
Veterinary Infection Prevention
Related Content